Aberrant integration of Hepatitis B virus DNA promotes major restructuring of human hepatocellular carcinoma genome architecture
Eva G. Álvarez(Universidade de Santiago de Compostela), José M. C. Tubío(Wellcome Sanger Institute), Kazuhiro Maejima(RIKEN Center for Integrative Medical Sciences), Ana Pequeño‐Valtierra(Universidade de Santiago de Compostela), Keiran Raine(Wellcome Sanger Institute), Urtzi Garaigorta(Centro Nacional de Biotecnología), Aitor Rodríguez‐Casanova(Instituto de Investigación Sanitaria de Santiago), Jonas Demeulemeester(The Francis Crick Institute), Kazuaki Chayama(RIKEN Center for Integrative Medical Sciences), Ana Oitabén(Universidade de Santiago de Compostela), Iago Otero(Universidade de Santiago de Compostela), Peter J. Campbell(Wellcome Sanger Institute), Hiroshi Aikata(Hiroshima Prefectural Hospital), Xavier Forns(Hospital Clínic de Barcelona), Alicia L. Bruzos(Centre National de la Recherche Scientifique), Rosanna Abal(Universidade de Santiago de Compostela), Bernardo Rodríguez–Martín(Universidade de Santiago de Compostela), Atsushi Ono(Hiroshima University), Raúl Torres(Spanish National Cancer Research Centre), Carmen Rivas(Centro Nacional de Biotecnología), Ángel Díaz‐Lagares(Epigenomics (Germany)), Jorge Rodríguez‐Castro(Universidade de Santiago de Compostela), Sofía Pérez‐del‐Pulgar(Hospital Clínic de Barcelona), Mónica Martínez‐Fernández(Universidade de Santiago de Compostela), Juan Ruiz‐Bañobre(Universidade de Santiago de Compostela), Adrian Baez‐Ortega(University of Cambridge), Sandra Rodríguez(Spanish National Cancer Research Centre), Daniel García‐Souto(Universidade de Santiago de Compostela), Masaki Ueno(Wakayama Medical University), Javier Temes(Universidade de Santiago de Compostela), Hiroki Yamaue(Wakayama Medical University), Peter Van Loo(Wellcome Sanger Institute), Jorge Zamora(Universidade de Santiago de Compostela), Kerstin Haase(The Francis Crick Institute), Hidewaki Nakagawa(RIKEN Center for Integrative Medical Sciences), Yilong Li(Guizhou Academy of Agricultural Sciences), Shinya Hayami(Wakayama Medical University), Paula Otero(Universidade de Santiago de Compostela), Miguel G. Blanco(Universidade de Santiago de Compostela), Adam P. Butler(Wellcome Sanger Institute), Sonia Zumalave(European Bioinformatics Institute), Marta Tojo(Universidade de Vigo), Clemency Jolly(The Francis Crick Institute)
Cited by 56
Related Papers
Signatures of mutational processes in human cancer
|Nature|2013|10.1k
COSMIC: the Catalogue Of Somatic Mutations In Cancer
|Nucleic Acids Research|2018|5.2k
Genomic Classification and Prognosis in Acute Myeloid Leukemia
|New England Journal of Medicine|2016|4.4k
The cancer genome
|Nature|2009|3.5k
Acquired mutation of the tyrosine kinase JAK2 in human myeloproliferative disorders
|The Lancet|2005|3.4k